Shandong Wohua Pharmaceutical Co Ltd (002107) — Cash Flow-to-Debt Ratio
Shandong Wohua Pharmaceutical Co Ltd (002107) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2025, meaning its operating cash flow of CN¥27.12 Million could theoretically repay 0% of its total liabilities (CN¥280.66 Million) in one year. See 002107 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shandong Wohua Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2003–2025)
Historical debt coverage capacity for Shandong Wohua Pharmaceutical Co Ltd across 23 annual periods. Also explore Shandong Wohua Pharmaceutical Co Ltd (002107) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
Year-by-year debt coverage analysis for Shandong Wohua Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see market cap of Shandong Wohua Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.50x | CN¥128.53 Million | CN¥256.47 Million | ▲ +43.9% |
| 2024 | 0.35x | CN¥91.51 Million | CN¥262.80 Million | ▼ -16.1% |
| 2023 | 0.42x | CN¥129.25 Million | CN¥311.23 Million | ▼ -30.5% |
| 2022 | 0.60x | CN¥185.26 Million | CN¥310.20 Million | ▼ -30.8% |
| 2021 | 0.86x | CN¥200.12 Million | CN¥231.83 Million | ▲ +98.5% |
| 2020 | 0.43x | CN¥196.58 Million | CN¥452.08 Million | ▲ +219.9% |
| 2019 | 0.14x | CN¥31.66 Million | CN¥232.87 Million | ▼ -71.4% |
| 2018 | 0.48x | CN¥107.88 Million | CN¥226.60 Million | ▼ -23.2% |
| 2017 | 0.62x | CN¥123.88 Million | CN¥199.71 Million | ▲ +13.1% |
| 2016 | 0.55x | CN¥72.91 Million | CN¥132.99 Million | ▼ -50.1% |
| 2015 | 1.10x | CN¥132.82 Million | CN¥120.97 Million | ▲ +52.4% |
| 2014 | 0.72x | CN¥26.58 Million | CN¥36.89 Million | ▲ +90.2% |
| 2013 | 0.38x | CN¥15.15 Million | CN¥40.01 Million | ▼ -44.9% |
| 2012 | 0.69x | CN¥33.86 Million | CN¥49.28 Million | ▲ +1729.9% |
| 2011 | 0.04x | CN¥1.36 Million | CN¥36.28 Million | ▲ +111.2% |
| 2010 | -0.34x | CN¥-15.28 Million | CN¥45.49 Million | ▼ -35.1% |
| 2009 | -0.25x | CN¥-21.24 Million | CN¥85.41 Million | ▼ -151.9% |
| 2008 | 0.48x | CN¥35.59 Million | CN¥74.23 Million | ▲ +405.8% |
| 2007 | 0.09x | CN¥10.46 Million | CN¥110.32 Million | ▼ -80.6% |
| 2006 | 0.49x | CN¥46.05 Million | CN¥94.44 Million | ▲ +214.4% |
| 2005 | 0.16x | CN¥13.01 Million | CN¥83.88 Million | ▼ -67.7% |
| 2004 | 0.48x | CN¥33.77 Million | CN¥70.30 Million | ▲ +120.1% |
| 2003 | 0.22x | CN¥18.17 Million | CN¥83.28 Million | — |